COCRYSTAL PHARMA INC (COCP) Stock Analyst Earnings Estimates
NASDAQ:COCP - Nasdaq - US19188J4094 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.56M | 2.01M -69.36% | -100.00% | |||||||
| EBITDA YoY % growth | -8.97M -9.93% | -2.21M 75.36% | -9.43M -326.70% | N/A -48.78% | N/A -27.94% | -20.137M -16.82% | -21.044M -0.35% | -17.479M 16.94% | N/A | |
| EBIT YoY % growth | -9.02M -9.20% | -2.31M 74.39% | -9.59M -315.15% | -14.707M -48.28% | -40.93M -27.57% | -19.821M -16.64% | -20.628M 2.51% | -23.409M -13.48% | -26.826M -14.60% | |
| Operating Margin | N/A | -35.21% | -477.11% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -0.72 76.47% | -2.28 -216.67% | -1.96 15.79% | -4.18 -146.35% | -2.14 59.83% | -1.97 -3.61% | -2.20 -11.92% | -2.63 -19.44% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 -22.86% | -0.58 -49.08% | -0.55 -3.92% | -0.49 0.08% | -0.48 11.32% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.712M -0.81% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.49 -19.51% | -0.58 | 0.09 | 15.72% |
| Q2 2024 Q2Q % growth | -0.53 -29.27% | -0.49 | -0.04 | -9.01% |
| Q1 2024 Q2Q % growth | -0.39 39.06% | -0.55 | 0.16 | 29.19% |
| Q4 2023 Q2Q % growth | -0.44 20.00% | -0.61 | 0.17 | 27.70% |
| Q3 2023 Q2Q % growth | -0.41 41.43% | -0.54 | 0.13 | 24.16% |
| Q2 2023 Q2Q % growth | -0.41 86.33% | -0.59 | 0.18 | 30.70% |
| Q1 2023 Q2Q % growth | -0.64 -33.33% | -0.69 | 0.05 | 7.04% |
| Q4 2022 Q2Q % growth | -0.55 -14.58% | -0.74 | 0.19 | 25.80% |
| Q3 2022 Q2Q % growth | -0.70 -45.83% | -0.49 | -0.21 | -42.97% |
| Q2 2022 Q2Q % growth | -3.00 -525.00% | -0.53 | -2.47 | -465.65% |
| Q1 2022 Q2Q % growth | -0.48 | -0.43 | -0.05 | -12.04% |
| Q4 2021 Q2Q % growth | -0.48 -100.00% | -0.49 | 0.01 | 1.96% |
| Q3 2021 Q2Q % growth | -0.48 20.00% | -0.49 | 0.01 | 1.96% |
| Q2 2021 Q2Q % growth | -0.48 42.86% | -0.43 | -0.05 | -12.04% |
| Q1 2021 Q2Q % growth | -0.48 20.00% | -0.55 | 0.07 | 12.85% |
| Q4 2020 Q2Q % growth | -0.24 60.00% | -0.49 | 0.25 | 50.98% |
| Q3 2020 Q2Q % growth | -0.60 16.67% | -0.61 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | -0.84 -40.00% | -0.49 | -0.35 | -71.57% |
| Q1 2020 Q2Q % growth | -0.60 -150.00% | -0.98 | 0.38 | 38.73% |
| Q4 2019 Q2Q % growth | -0.60 | -0.86 | 0.26 | 29.97% |
| Q3 2019 Q2Q % growth | -0.72 | -0.98 | 0.26 | 26.47% |
| Q2 2019 Q2Q % growth | -0.60 | -0.86 | 0.26 | 29.97% |
| Q1 2019 Q2Q % growth | 1.20 | -0.98 | 2.18 | 222.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 272.003K | -272.003K | -100.00% | |
| Q1 2023 Q2Q % growth | 255K | -255K | -100.00% | |
| Q3 2022 Q2Q % growth | 84.997K | -84.997K | -100.00% | |
| Q2 2022 Q2Q % growth | 84.997K | -84.997K | -100.00% | |
| Q1 2022 Q2Q % growth | 637.5K | -637.5K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 280.5K | -280.5K | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 280.5K | -280.5K | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 561K | -561K | -100.00% |
| Q4 2020 Q2Q % growth | 510K 27.50% | 591.6K | -81.6K | -13.79% |
| Q3 2020 Q2Q % growth | 490K | 571.2K | -81.2K | -14.22% |
| Q2 2020 Q2Q % growth | 550K -6.78% | 459K | 91K | 19.83% |
| Q1 2020 Q2Q % growth | 460K -90.94% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 5.36% | 0% | 1.53% |
| Revenue | N/A | N/A | N/A | N/A |